Home » Newsletters » BioWorld Science

BioWorld Science

March 1, 2017

View Archived Issues

ATYR-1940 granted U.S. orphan drug designation for the treatment of limb girdle muscular dystrophy

FDA grants orphan drug designation to ustekinumab for the treatment of pediatric ulcerative colitis

EMA committee hands down positive opinion for 8-week regimen of Viekirax + Exviera

FDA requests additional information to complete IND review for Titan's ropinirole implant

FDA awards fast track designation to Immunopulse IL-12 for metastatic melanoma

WHO publishes list of antibiotic-resistant priority pathogens

Sanofi seeks Japanese approval for dupilumab for atopic dermatitis

FDA grants rare pediatric disease designation to SB-318 for MPS I

Phase III pediatric study of Latuda for bipolar I depression meets primary endpoint

Immune Pharmaceuticals broadens enrollment criteria in bullous pemphigoid study of bertilimumab

Accera announces results from phase III study of AC-1204 for mild to moderate Alzheimer's disease

Bremelanotide improves desire and distress in hypoactive sexual desire disorder

miR-223 found to play a role in alcoholic liver disease

Astellas and Affinivax enter worldwide partnership for MAPS vaccine targeting pneumococcus

Vycellix and Moffitt Cancer Center establish collaborative research agreement

TGFB2 has a pathogenic role in Alzheimer's disease and dementia with Lewy bodies

Cancer Research UK and HitGen announce license agreement in lung cancer

Kevzara becomes available in Canada

Immunologic responses seen with vesigenurtucel-L in non-muscle invasive bladder cancer

FDA grants priority review to avelumab BLA for metastatic urothelial carcinoma

Johnson & Johnson completes acquisition of Abbott Medical Optics

Perrigo signs agreement to divest Tysabri royalty stream

FDA approves Xermelo for carcinoid syndrome diarrhea

ZUMA-1 study of axicabtagene ciloleucel meets primary endpoint of objective response rate

FDA accepts Dynavax's response to Heplisav-B complete response letter

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...